Press Releases August 31, 2026 04:01 PM

Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14

Kestra Medical Technologies to announce Q1 fiscal 2027 financial results on September 14

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
KMTS

Kestra Medical Technologies, a wearable medical device and digital healthcare company, will report its first quarter fiscal 2027 financial results after market close on September 14, followed by a management conference call.

Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14
KMTS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Kestra Medical Technologies focuses on cardiovascular disease through wearable monitoring and therapeutic technologies.
  • The company’s financial results for the first quarter of fiscal 2027 will be released on September 14.
  • A conference call and webcast will be available for investors and analysts to discuss results.

KIRKLAND, Wash., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report first quarter fiscal 2027 financial results after the market closes on Monday, September 14.

Management will host a conference call at 4:30 p.m. Eastern Time to discuss financial results. A live and archived webcast of the conference call will be available in the “Events” section of the investor relations website.

About Kestra
Kestra Medical Technologies, Ltd. is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.


Risks

  • Financial performance unknown until results are announced, which may lead to market uncertainty.
  • Dependence on successful adoption of wearable medical devices and digital health technologies.
  • Risks related to competitive pressures in the medical device and digital healthcare sectors.

More from Press Releases

Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company Sep 2, 2026 uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease Sep 2, 2026 Teva Announces Positive Topline Results from Phase 2a Study in Celiac Disease for Its Anti-IL-15 Antibody, Further Validating Its Pipeline-in-a-Product Potential Sep 2, 2026 Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference Sep 2, 2026 Aeluma to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on September 16, 2026 Sep 2, 2026